微小RNA-373在肿瘤中的作用

国际肿瘤学杂志››2018,Vol. 45››Issue (6): 355-357.doi:10.3760/cma.j.issn.1673-422X.2018.06.008

沈凯，邵芳，冯同保，戚春建

213000 南京医科大学附属常州市第二人民医院肿瘤研究所（沈凯、邵芳、戚春建），检验科（冯同保）

收稿日期:2018-03-13出版日期:2018-06-08发布日期:2018-07-31
通讯作者:戚春建 E-mail:qichunjian@njmu.edu.cn
基金资助:

国家自然科学基金（31501942,31601156）

Role of microRNA-373 in tumor

Shen Kai, Shao Fang, Feng Tongbao, Qi Chunjian

Tumor Research Center, Changzhou Second People′s Hospital, Nanjing Medical University, Changzhou 213000, China

Received:2018-03-13Online:2018-06-08Published:2018-07-31
Contact:Qi Chunjian E-mail:qichunjian@njmu.edu.cn
Supported by:

National Natural Science Foundation of China (31501942, 31601156)

摘要/Abstract

摘要：微小RNA是参与转录后基因表达调控的非编码小RNA，在不同肿瘤中起抑癌或促癌作用。微小RNA-373是微小RNA-520/373家族成员之一，它参与肿瘤的缺氧反应和DNA损伤修复。微小RNA-373在乳腺癌、胶质瘤、肺癌、前列腺癌等肿瘤中异常表达，可能在其发展过程特别是肿瘤入侵和迁移中起重要作用。

沈凯，邵芳，冯同保，戚春建. 微小RNA-373在肿瘤中的作用[J]. 国际肿瘤学杂志, 2018, 45(6): 355-357.

Shen Kai, Shao Fang, Feng Tongbao, Qi Chunjian. Role of microRNA-373 in tumor[J]. Journal of International Oncology, 2018, 45(6): 355-357.

［1］ Wei F, Cao C, Xu X, et al. Diverse functions of miR-373 in cancer［J］. J Transl Med, 2015, 13: 162. DOI: 10.1186/s12967-015-0523-z. ［2］ Zhang Y, Yang J, Cui X, et al. A novel epigenetic CREBmiR-373 axis mediates ZIP4induced pancreatic cancer growth［J］. EMBO Mol Med, 2013, 5(9): 1322-1334. DOI: 10.1002/emmm.201302507. ［3］ Meng X, Müller V, MildeLangosch K, et al. Diagnostic and prognostic relevance of circulating exosomal miR373, miR200a, miR200b and miR-200c in patients with epithelial ovarian cancer［J］. Oncotarget, 2016, 7(13): 16923-16935. DOI: 10.18632/oncotarget.7850. ［4］ Chen D, Dang BL, Huang JZ, et al. MiR-373 drives the epithelial to mesenchymal transition and metastasis via the miR373TXNIPHIF1αTWIST signaling axis in breast cancer［J］. Oncotarget, 2015, 6(32): 3270132712. DOI: 10.18632/oncotarget.4702. ［5］ Ding W, Fan XL, Xu X, et al. Epigenetic silencing of ITGA2 by miR-373 promotes cell migration in breast cancer［J］. PLoS One, 2015, 10(8): e0135128. DOI: 10.1371/journal.pone.0135128. ［6］ O′Day E, Lal A. MicroRnas and their target gene networks in breast cancer［J］. Breast Cancer Res, 2010, 12(2): 201. DOI: 10.1186/bcr2484. ［7］ Keklikoglou I, Koerner C, Schmidt C, et al. MicroRNA520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGFβ signaling pathways［J］. Oncogene, 2012, 31(37): 41504163. DOI: 10.1038/onc.2011.571. ［8］ Jing SY, Jing SQ, Liu LL, et al. Downexpression of miR373 predicts poor prognosis of glioma and could be a potential therapeutic target［J］. Eur Rev Med Pharmacol Sci, 2017, 21(10): 2421-2425. ［9］ Wei F, Wang Q, Su Q, et al. miR373 inhibits glioma cell U251 migration and invasion by downregulating CD44 and TGFBR2［J］. Cell Mol Neurobiol, 2016, 36(8): 1389-1397. DOI: 10.1007/s10571-016-0338-3. ［10］ Lu S, Zhu Q, Zhang Y, et al. Dualfunctions of miR373 and miR520c by differently regulating the activities of MMP2 and MMP9［J］. J Cell Physiol, 2015, 230(8): 1862-1870. DOI: 10.1002/jcp.24914. ［11］ Seol HS, Akiyama Y, Shimada S, et al. Epigenetic silencing of microRNA373 to epithelialmesenchymal transition in nonsmall cell lung cancer through IRAK2 and LAMP1 axes ［J］. Cancer Lett, 2014, 353(2): 232-241. DOI: 10.1016/j.canlet.2014.07.019. ［12］ Wu W, He X, Kong J, et al. Mir373 affects human lung cancer cells′ growth and its Ecadherin expression［J］. Oncol Res, 2012, 20(4): 163-170. ［13］ Adi Harel S, Bossel BenMoshe N, Aylon Y, et al. Reactivation of epigenetically silenced miR512 and miR373 sensitizes lung cancer cells to cisplatin and restricts tumor growth［J］. Cell Death Differ, 2015, 22(8): 1328-1340. DOI: 10.1038/cdd.2014.221. ［14］ Wang L, Qu J, Zhou L, et al. MicroRNA-373 inhibits cell proliferation and invasion via targeting BRF2 in human nonsmall cell lung cancer A549 cell line［J］. Cancer Res Treat, 2017, In press. DOI: 10.4143/crt.2017.302. ［15］ Iczkowski KA. Cell adhesion molecule CD44: its functional roles in prostate cancer［J］. Am J Transl Res, 2010, 3(1): 1-7. ［16］ Yang K, Handorean AM, Iczkowski KA. MicroRNAs 373 and 520c are downregulated in prostate cancer, suppress CD44 translation and enhance invasion of prostate cancer cells in vitro［J］. Int J Clin Exp Pathol, 2009, 2(4): 361-369. ［17］ Walter BA, Valera VA, Pinto PA, et al. Comprehensive microRNA profiling of prostate cancer［J］. J Cancer, 2013, 4(5): 350-357. DOI: 10.7150/jca.6394. ［18］ Qiu X, Zhu J, Sun Y, et al. TR4 nuclear receptor increases prostate cancer invasion via decreasing the miR3733p expression to alter TGFβR2/p Smad3 signals［J］. Oncotarget, 2015, 6(17): 15397-15409. DOI: 10.18632/oncotarget.3778. ［19］ Hua Y, Chen H, Wang L, et al. Low serum miR373 predicts poor prognosis in patients with pancreatic cancer［J］. Cancer Biomark, 2017, 20(1): 95-100. DOI: 10.3233/CBM-170231. ［20］ Nakata K, Ohuchida K, Mizumoto K, et al. Micro RNA373 is downregulated in pancreatic cancer and inhibits cancer cell invasion［J］. Ann Surg Oncol, 2014, 21 Suppl 4: S564-574. DOI: 10.1245/s10434-014-3676-8. ［21］ Chen YJ, Luo J, Yang GY, et al. Mutual regulation between microRNA-373 and methylCpGbinding domain protein 2 in hilar cholangiocarcinoma ［J］. World J Gastroenterol, 2012, 18(29): 3849-3861. DOI: 10.3748/wjg.v18.i29.3849. ［22］ Chen Y, Gao W, Luo J, et al. MethylCpG binding protein MBD2 is implicated in methylationmediated suppression of miR-373 in hilar cholangiocarcinoma［J］. Oncol Rep, 2011, 25(2): 443-451. DOI: 10.3892/or.2010.1089.

[1]	刘娜, 寇介丽, 杨枫, 刘桃桃, 李丹萍, 韩君蕊, 杨立洲.血清miR-106b-5p、miR-760联合低剂量螺旋CT诊断早期肺癌的临床价值[J]. 国际肿瘤学杂志, 2024, 51(6): 321-325.
[2]	杨蜜, 别俊, 张加勇, 邓佳秀, 唐组阁, 卢俊.局部晚期可切除食管癌新辅助治疗疗效及预后分析[J]. 国际肿瘤学杂志, 2024, 51(6): 332-337.
[3]	袁健, 黄燕华.Hp-IgG抗体联合血清DKK1、sB7-H3对早期胃癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(6): 338-343.
[4]	陈红健, 张素青.血清miR-24-3p、H2AFX与肝癌患者临床病理特征及术后复发的关系研究[J]. 国际肿瘤学杂志, 2024, 51(6): 344-349.
[5]	郭泽浩, 张俊旺.PFDN及其亚基在肿瘤发生发展中的作用[J]. 国际肿瘤学杂志, 2024, 51(6): 350-353.
[6]	张百红, 岳红云.新作用机制的抗肿瘤药物进展[J]. 国际肿瘤学杂志, 2024, 51(6): 354-358.
[7]	许凤琳, 吴刚.EBV在鼻咽癌肿瘤免疫微环境和免疫治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 359-363.
[8]	王盈, 刘楠, 郭兵.抗体药物偶联物在转移性乳腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 364-369.
[9]	张蕊, 褚衍六.基于FIT与肠道菌群的结直肠癌风险评估模型的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 370-375.
[10]	高凡, 王萍, 杜超, 褚衍六.肠道菌群与结直肠癌非手术治疗的相关研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 376-381.
[11]	王丽, 刘志华, 杨伟洪, 蒋凤莲, 李全泳, 宋浩杰, 鞠文东.ROS1突变肺腺鳞癌合并脑梗死为主要表现的Trousseau综合征1例[J]. 国际肿瘤学杂志, 2024, 51(6): 382-384.
[12]	刘静, 刘芹, 黄梅.基于SMOTE算法的食管癌放化疗患者肺部感染的预后模型构建[J]. 国际肿瘤学杂志, 2024, 51(5): 267-273.
[13]	杨琳, 路宁, 温华, 张明鑫, 朱琳.炎症负荷指数与胃癌临床关系研究[J]. 国际肿瘤学杂志, 2024, 51(5): 274-279.
[14]	王俊毅, 洪楷彬, 纪荣佳, 陈大朝.癌结节对结直肠癌根治性切除术后肝转移的影响[J]. 国际肿瘤学杂志, 2024, 51(5): 280-285.
[15]	张宁宁, 杨哲, 檀丽梅, 李振宁, 王迪, 魏永志.宫颈细胞DNA倍体分析联合B7-H4和PKCδ对宫颈癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(5): 286-291.